# China could ‘corner’ biopharmaceutical sector with new plan, US panel warns

Source: [BioPharma Dive - Latest News](https://www.biopharmadive.com/news/us-china-biotech-report-commission-supply-chain-2026/875170/) · 2026-11-19 · Medicine
Page: https://themorning.science/story/china-could-corner-biopharmaceutical-sector-with-new-plan-us-panel-warns-9c24358bca86bccb
Kind: policy · Impact: medium

## In brief

- A US commission warned of an overdependence on China in biopharmaceuticals.
- The commission urged US lawmakers to act quickly to prevent that overdependence.
- The commission said American patients could become vulnerable to supply chain weaponization.

## Why it matters

Heavy reliance on a single foreign country for drug supply chains could expose patients and producers to disruption or political pressure, which matters for anyone tracking medicine supply and biotech policy.

## Timeline

- 2026-11-19: US commission warns of overdependence on China in biopharmaceuticals and urges lawmakers to act quickly

## Coverage

- [China could ‘corner’ biopharmaceutical sector with new plan, US panel warns](https://www.biopharmadive.com/news/us-china-biotech-report-commission-supply-chain-2026/875170/) — BioPharma Dive - Latest News, 2026-11-19

Tags: biopharmaceuticals, supply chain, china, us policy, drug security, biotech

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
